{"url_path":"/sec/tgen/8-k/2026-07-01/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-01","source_url":"https://www.sec.gov/Archives/edgar/data/1537435/0001537435-26-000053-index.html","accession_number":"0001537435-26-000053","cik":"0001537435","ticker":"TGEN","issuer_name":"TECOGEN INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1537435/0001537435-26-000053-index.html","primary_entity_key":"0001537435","primary_entity_name":"TECOGEN INC."},"word_count":341,"has_tables":true,"body_markdown":"Item 5.02. Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers.\n\nOn June 26, 2026, the Compensation Committee of Tecogen Inc. (the “Company”) recommended to the Company’s Board of Directors that in order to align the economic interests of the Company’s Chief Executive Officer, Abinand Rangesh, and its other named executive officers with the interests of the Company and its stockholders, the Company grant to them the following awards of restricted stock and incentive stock options pursuant to the Company’s 2022 Stock Incentive Plan. The Company’s Board of Directors approved such awards at a meeting held on June 26, 2026.\n\nNamed Executive OfficerEquity Grant\nNumber of Shares of Restricted Stock or Shares Underlying Options\n\nAbinand Rangesh, CEORestricted Stock Award 174,081\n\nIncentive Stock Option26,041\n\nRobert A. Panora, President and COORestricted Stock Award9,671\n\nIncentive Stock Option26,041\n\nRoger Deschenes, CFORestricted Stock Award29,013\n\nStephen Lafaille, VP of Business DevelopmentRestricted Stock Award29,013\n\nJohn K. Whiting, IV, General Counsel & SecretaryRestricted Stock Award19,342\n\nEach of such awards vests in equal installments on the first, second, third, and fourth anniversaries of the date of grant. The incentive stock options are exercisable at a price of $5.17 per share.\n\nIn addition, the Compensation Committee also recommended to the Board, and the Board approved at the above referenced meeting, increases in the cash compensation payable to Mr. Rangesh and each named executive officer. Mr. Rangesh’s annual base salary was increased by 5% to $220,500; and each named executive officer’s base salary was increased by 3% as follows: Mr. Panora’s annual base salary was increased to $206,000; Mr. Deschenes’ annual base salary was increased to $185,400; Mr. Lafaille’s annual base salary was increased to $152,260; and Mr. Whiting’s annual base salary was increased to $185,400.\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.\n\nTECOGEN INC.\n\nBy: /s/ Abinand Rangesh\n\nJuly 1, 2026Abinand Rangesh, Chief Executive Officer\n\nPrincipal Executive Officer"}